Early growth response 2 (Egr-2) expression is triggered by NF-κB activation

Molecular and Cellular Neuroscience

Volumn 64, Issue , 2015, Pages 95-103

  Nafez, Solmaz ^a   Oikawa, Kensuke ^a   Odero, Gary L ^b   Sproule, Michael ^b   Ge, Ning ^b   Schapansky, Jason ^a   Abrenica, Bernard ^b   Hatherell, Avril ^b   Cadonic, Chris ^a   Zhang, Shunzhen ^c   Song, Xiaohua ^d   Kauppinen, Tiina ^a   Glazner, Gordon W ^a   Grilli, Mariagrazia ^e   Czubryt, Michael P ^a   Eisenstat, David D ^d   Albensi, Benedict C ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

^b ST BONIFACE GENERAL HOSPITAL   (Canada)

^c UNIVERSITY OF MANITOBA   (Canada)

^d UNIVERSITY OF ALBERTA   (Canada)

^e UNIVERSITY OF EASTERN PIEDMONT   (Italy)

Author keywords

Egr; Gene expression; Memory; NF B; Signal transduction; Transcription factor

Indexed keywords

EARLY GROWTH RESPONSE FACTOR 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; SMALL INTERFERING RNA; TRANSCRIPTOME; TUMOR NECROSIS FACTOR ALPHA; EGR2 PROTEIN, MOUSE; PROTEIN BINDING;

ANIMAL EXPERIMENT; ARTICLE; BINDING SITE; BRAIN CELL; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; ELECTROSTIMULATION; GENETIC TRANSCRIPTION; HELA CELL LINE; HIPPOCAMPUS; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; KNOCKOUT MOUSE; LUCIFERASE ASSAY; MOUSE; NEUROBLASTOMA CELL; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; UPREGULATION; ANIMAL; GENETICS; METABOLISM; PHYSIOLOGY; TRANSCRIPTION INITIATION;

MUS;

ANIMALS; EARLY GROWTH RESPONSE PROTEIN 2; HELA CELLS; HIPPOCAMPUS; HUMANS; MICE; NF-KAPPA B P50 SUBUNIT; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; TRANSCRIPTIONAL ACTIVATION;

EID: 84920894251     PISSN: 10447431     EISSN: 10959327     Source Type: Journal    
DOI: 10.1016/j.mcn.2014.12.008     Document Type: Article

References (52)

1. Abraham W.C., Dragunow M., Tate W.P. The role of immediate early genes in the stabilization of long-term potentiation. Mol. Neurobiol. 1991, 5:297-314.
2. Ahn H.J., Levenson J.M., Lubin F.D., Liou H.C., Sweatt J.D. c-Rel, an NF-kappaB family transcription factor, is required for hippocampal long-term synaptic plasticity and memory formation. Learn. Mem. 2008, 15:539-549.
3. Albensi B.C., Mattson M.P. Evidence for the involvement of TNF and NF-kappaB in hippocampal synaptic plasticity. Synapse 2000, 35:151-159.
4. Alberini C.M. Transcription factors in long-term memory and synaptic plasticity. Physiol. Rev. 2009, 89:121-145.
5. An G., Lin T.N., Liu J.S., Hsu C.Y. Induction of Krox-20 expression after focal cerebral ischemia. Biochem. Biophys. Res. Commun. 1992, 188:1104-1110.
6. Baldwin A.S. The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu. Rev. Immunol. 1996, 14:649-683.
7. Barco A., Patterson S., Alarcon J.M., Gromova P., Mata-Roig M., Morozov A., Kandel E.R. Gene expression profiling of facilitated L-LTP in VP16-CREB mice reveals that BDNF is critical for the maintenance of LTP and its synaptic capture. Neuron 2005, 48:123-137.
8. Beckmann A.M., Wilce P.A. Egr transcription factors in the nervous system. Neurochem. Int. 1997, 31:477-510. (discussion 517-476).
9. Bellone E., Di Maria E., Soriani S., Varese A., Doria L.L., Ajmar F., Mandich P. A novel mutation (D305V) in the early growth response 2 gene is associated with severe Charcot-Marie-Tooth type 1 disease. Hum. Mutat. 1999, 14:353-354.
10. Bhat R.V., Worley P.F., Cole A.J., Baraban J.M. Activation of the zinc finger encoding gene krox-20 in adult rat brain: comparison with zif268. Brain Res. Mol. Brain Res. 1992, 13:263-266.
11. Bhattacharyya S., Wu M., Fang F., Tourtellotte W., Feghali-Bostwick C., Varga J. Early growth response transcription factors: key mediators of fibrosis and novel targets for anti-fibrotic therapy. Matrix Biol. 2011, 30:235-242.
12. Boothby M. Specificity of sn50 for NF-kappa B?. Nat. Immunol. 2001, 2:471-472.
13. Cao S., Zhang X., Edwards J.P., Mosser D.M. NF-kappaB1 (p50) homodimers differentially regulate pro- and anti-inflammatory cytokines in macrophages. J. Biol. Chem. 2006, 281:26041-26050.
14. Cole A.J., Saffen D.W., Baraban J.M., Worley P.F. Rapid increase of an immediate early gene messenger RNA in hippocampal neurons by synaptic NMDA receptor activation. Nature 1989, 340:474-476.
15. Dillon R.L., Brown S.T., Ling C., Shioda T., Muller W.J. An EGR2/CITED1 transcription factor complex and the 14-3-3sigma tumor suppressor are involved in regulating ErbB2 expression in a transgenic-mouse model of human breast cancer. Mol. Cell. Biol. 2007, 27:8648-8657.
16. Dolga A.M., Granic I., Blank T., Knaus H.G., Spiess J., Luiten P.G., Eisel U.L., Nijholt I.M. TNF-alpha-mediates neuroprotection against glutamate-induced excitotoxicity via NF-kappaB-dependent up-regulation of K2.2 channels. J. Neurochem. 2008, 107:1158-1167.
17. Dragunow M. A role for immediate-early transcription factors in learning and memory. Behav. Genet. 1996, 26:293-299.
18. Ghosh S., May M.J., Kopp E.B. NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol. 1998, 16:225-260.
19. Gomez-Martin D., Diaz-Zamudio M., Galindo-Campos M., Alcocer-Varela J. Early growth response transcription factors and the modulation of immune response: implications towards autoimmunity. Autoimmun. Rev. 2010, 9:454-458.
20. Herdegen T., Brecht S., Mayer B., Leah J., Kummer W., Bravo R., Zimmermann M. Long-lasting expression of JUN and KROX transcription factors and nitric oxide synthase in intrinsic neurons of the rat brain following axotomy. J. Neurosci. 1993, 13:4130-4145.
21. Herdegen T., Kiessling M., Bele S., Bravo R., Zimmermann M., Gass P. The KROX-20 transcription factor in the rat central and peripheral nervous systems: novel expression pattern of an immediate early gene-encoded protein. Neuroscience 1993, 57:41-52.
22. Herdegen T., Sandkuhler J., Gass P., Kiessling M., Bravo R., Zimmermann M. JUN, FOS, KROX, and CREB transcription factor proteins in the rat cortex: basal expression and induction by spreading depression and epileptic seizures. J. Comp. Neurol. 1993, 333:271-288.
23. Jessen K.R., Mirsky R. Signals that determine Schwann cell identity. J. Anat. 2002, 200:367-376.
24. Kamholz J., Menichella D., Jani A., Garbern J., Lewis R.A., Krajewski K.M., Lilien J., Scherer S.S., Shy M.E. Charcot-Marie-Tooth disease type 1: molecular pathogenesis to gene therapy. Brain 2000, 123(Pt 2):222-233.
25. Kandel E.R. The molecular biology of memory storage: a dialogue between genes and synapses. Science 2001, 294:1030-1038.
26. Kao S.C., Wu H., Xie J., Chang C.P., Ranish J.A., Graef I.A., Crabtree G.R. Calcineurin/NFAT signaling is required for neuregulin-regulated Schwann cell differentiation. Science 2009, 323:651-654.
27. Kassed C.A., Herkenham M. NF-kappaB p50-deficient mice show reduced anxiety-like behaviors in tests of exploratory drive and anxiety. Behav. Brain Res. 2004, 154:577-584.
28. Lemberger T., Parkitna J.R., Chai M., Schutz G., Engblom D. CREB has a context-dependent role in activity-regulated transcription and maintains neuronal cholesterol homeostasis. FASEB J. 2008, 22:2872-2879.
29. Matheny C., Day M.L., Milbrandt J. The nuclear localization signal of NGFI-A is located within the zinc finger DNA binding domain. J. Biol. Chem. 1994, 269:8176-8181.
30. Mattson M.P. NF-kappaB in the survival and plasticity of neurons. Neurochem. Res. 2005, 30:883-893.
31. Mattson M.P., Camandola S. NF-kappaB in neuronal plasticity and neurodegenerative disorders. J. Clin. Invest. 2001, 107:247-254.
32. Mattson M.P., Culmsee C., Yu Z., Camandola S. Roles of nuclear factor kappaB in neuronal survival and plasticity. J. Neurochem. 2000, 74:443-456.
33. Mayeux R., Saunders A.M., Shea S., Mirra S., Evans D., Roses A.D., Hyman B.T., Crain B., Tang M.X., Phelps C.H. Utility of the apolipoprotein E genotype in the diagnosis of Alzheimer's disease. Alzheimer's Disease Centers Consortium on Apolipoprotein E and Alzheimer's Disease. N. Engl. J. Med. 1998, 338:506-511.
34. Miyashita T., Kubik S., Lewandowski G., Guzowski J.F. Networks of neurons, networks of genes: an integrated view of memory consolidation. Neurobiol. Learn. Mem. 2008, 89:269-284.
35. Nickols J.C., Valentine W., Kanwal S., Carter B.D. Activation of the transcription factor NF-kappaB in Schwann cells is required for peripheral myelin formation. Nat. Neurosci. 2003, 6:161-167.
36. O'Donovan K.J., Tourtellotte W.G., Millbrandt J., Baraban J.M. The EGR family of transcription-regulatory factors: progress at the interface of molecular and systems neuroscience. Trends Neurosci. 1999, 22:167-173.
37. Oikawa K., Odero G.L., Platt E., Neuendorff M., Hatherell A., Bernstein M.J., Albensi B.C. NF-kappa B p50 subunit knockout impairs late LTP and alters long term memory in the mouse hippocampus. BMC Neurosci. 2012, 13:45.
38. Pahl H.L. Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene 1999, 18:6853-6866.
39. Pannaccione A., Secondo A., Scorziello A., Cali G., Taglialatela M., Annunziato L. Nuclear factor-kappaB activation by reactive oxygen species mediates voltage-gated K+ current enhancement by neurotoxic beta-amyloid peptides in nerve growth factor-differentiated PC-12 cells and hippocampal neurones. J. Neurochem. 2005, 94:572-586.
40. Safford M., Collins S., Lutz M.A., Allen A., Huang C.T., Kowalski J., Blackford A., Horton M.R., Drake C., Schwartz R.H., Powell J.D. Egr-2 and Egr-3 are negative regulators of T cell activation. Nat. Immunol. 2005, 6:472-480.
41. Schwamborn J., Lindecke A., Elvers M., Horejschi V., Kerick M., Rafigh M., Pfeiffer J., Prullage M., Kaltschmidt B., Kaltschmidt C. Microarray analysis of tumor necrosis factor alpha induced gene expression in U373 human glioblastoma cells. BMC Genomics 2003, 4:46.
42. Sekine K., Fujii H., Abe F., Nishikawa K. Augmentation of death ligand-induced apoptosis by aminopeptidase inhibitors in human solid tumor cell lines. Int. J. Cancer 2001, 94:485-491.
43. Sha W.C., Liou H.C., Tuomanen E.I., Baltimore D. Targeted disruption of the p50 subunit of NF-kappa B leads to multifocal defects in immune responses. Cell 1995, 80:321-330.
44. Single F.N., Rozov A., Burnashev N., Zimmermann F., Hanley D.F., Forrest D., Curran T., Jensen V., Hvalby O., Sprengel R., Seeburg P.H. Dysfunctions in mice by NMDA receptor point mutations NR1(N598Q) and NR1(N598R). J. Neurosci. 2000, 20:2558-2566.
45. Sung S., Yang H., Uryu K., Lee E.B., Zhao L., Shineman D., Trojanowski J.Q., Lee V.M., Pratico D. Modulation of nuclear factor-kappa B activity by indomethacin influences A beta levels but not A beta precursor protein metabolism in a model of Alzheimer's disease. Am. J. Pathol. 2004, 165:2197-2206.
46. Topilko P., Schneider-Maunoury S., Levi G., Baron-Van Evercooren A., Chennoufi A.B., Seitanidou T., Babinet C., Charnay P. Krox-20 controls myelination in the peripheral nervous system. Nature 1994, 371:796-799.
47. Williams J., Dragunow M., Lawlor P., Mason S., Abraham W.C., Leah J., Bravo R., Demmer J., Tate W. Krox20 may play a key role in the stabilization of long-term potentiation. Brain Res. Mol. Brain Res. 1995, 28:87-93.
48. Worley P.F., Bhat R.V., Baraban J.M., Erickson C.A., McNaughton B.L., Barnes C.A. Thresholds for synaptic activation of transcription factors in hippocampus: correlation with long-term enhancement. J. Neurosci. 1993, 13:4776-4786.
49. Yamagata K., Sanders L.K., Kaufmann W.E., Yee W., Barnes C.A., Nathans D., Worley P.F. rheb, a growth factor- and synaptic activity-regulated gene, encodes a novel Ras-related protein. J. Biol. Chem. 1994, 269:16333-16339.
50. Yoo Y.G., Lee M.O. Hepatitis B virus X protein induces expression of Fas ligand gene through enhancing transcriptional activity of early growth response factor. J. Biol. Chem. 2004, 279:36242-36249.
51. Zhong H., May M.J., Jimi E., Ghosh S. The phosphorylation status of nuclear NF-kappa B determines its association with CBP/p300 or HDAC-1. Mol. Cell 2002, 9:625-636.
52. Zhou Q.P., Le T.N., Qiu X., Spencer V., de Melo J., Du G., Plews M., Fonseca M., Sun J.M., Davie J.R., Eisenstat D.D. Identification of a direct Dlx homeodomain target in the developing mouse forebrain and retina by optimization of chromatin immunoprecipitation. Nucleic Acids Res. 2004, 32:884-892.